|
US5583024A
(en)
|
1985-12-02 |
1996-12-10 |
The Regents Of The University Of California |
Recombinant expression of Coleoptera luciferase
|
|
IL105456A
(en)
|
1992-04-21 |
1996-12-05 |
American Home Prod |
Vaccines of attenuated respiratory syncytial virus
|
|
AT401526B
(de)
|
1993-02-10 |
1996-09-25 |
Scheirer Winfried |
Reagenzlösung zur stabilisierung der lumineszenz bei der luciferasemessung
|
|
PT702085E
(pt)
|
1994-07-18 |
2004-04-30 |
Karl Klaus Conzelmann |
Virus de arn de cadeia negativa nao segmentada infeccioso recombinante
|
|
US7465574B2
(en)
|
1994-09-30 |
2008-12-16 |
Medimmune, Llc |
Recombinant RSV virus expression systems and vaccines
|
|
US7485440B2
(en)
|
1995-09-27 |
2009-02-03 |
The United States Of America As Represented By The Department Of Health And Human Services |
Production of attenuated respiratory syncytial virus vaccines involving modification of M2 ORF2
|
|
US6689367B1
(en)
|
1995-09-27 |
2004-02-10 |
The United States Of America As Represented By The Department Of Health And Human Services |
Production of attenuated chimeric respiratory syncytial virus vaccines from cloned nucleotide sequences
|
|
US6713066B1
(en)
|
1996-07-15 |
2004-03-30 |
The United States Of America As Represented By The Department Of Health And Human Services |
Production of attenuated respiratory syncytial virus vaccines involving modification of M2 ORF2
|
|
US6923971B2
(en)
|
1995-09-27 |
2005-08-02 |
The United States Of America As Represented By The Department Of Health & Human Services |
Respiratory syncytial virus vaccines expressing protective antigens from promoter-proximal genes
|
|
US7846455B2
(en)
|
1996-07-15 |
2010-12-07 |
The United States Of America As Represented By The Department Of Health And Human Services |
Attenuated chimeric respiratory syncytial virus
|
|
CA2230033C
(en)
|
1995-09-27 |
2010-01-26 |
Peter L. Collins |
Production of infectious respiratory syncytial virus from cloned nucleotide sequences
|
|
US6214805B1
(en)
|
1996-02-15 |
2001-04-10 |
The United States Of America As Represented By The Department Of Health And Human Services |
RNase L activators and antisense oligonucleotides effective to treat RSV infections
|
|
EP2112220A3
(en)
|
1996-07-15 |
2010-01-06 |
The Government of the United States of America, as represented by The Department of Health and Human Services |
Production of attenuated respiratory syncytial virus vaccines from cloned nucleotide sequences
|
|
US6699476B1
(en)
|
1996-07-15 |
2004-03-02 |
Peter L. Collins |
Production of recombinant respiratory syncytial viruses expressing immune modulatory molecules
|
|
US5976796A
(en)
|
1996-10-04 |
1999-11-02 |
Loma Linda University |
Construction and expression of renilla luciferase and green fluorescent protein fusion genes
|
|
US6074859A
(en)
|
1997-07-08 |
2000-06-13 |
Kikkoman Corporation |
Mutant-type bioluminescent protein, and process for producing the mutant-type bioluminescent protein
|
|
US20040005542A1
(en)
|
2001-06-22 |
2004-01-08 |
Krempl Christine D |
Respiratory syncytial virus vaccines expressing protective antigens from promotor- proximal genes
|
|
US20020018780A1
(en)
*
|
2000-05-25 |
2002-02-14 |
Scott Koenig |
Epitope-based vaccine for respiratory syncytial virus F-protein
|
|
JP4783726B2
(ja)
|
2003-03-28 |
2011-09-28 |
メディミューン，エルエルシー |
呼吸器合胞体ウイルスサブグループｂ株９３２０に関連する組成物および方法
|
|
EA011878B1
(ru)
|
2003-12-24 |
2009-06-30 |
Де Стат Дер Недерланден, Вертегенвордигд Дор Де Министер Ван Волксгезондхейд, Велзейн Ен Спорт |
Респираторно-синцитиальный вирус с перекрестно компенсированным геномным дефицитом
|
|
EP3312272B1
(en)
|
2004-10-08 |
2019-08-28 |
The Government of The United States of America as represented by The Secretary of The Department of Health and Human Services |
Modulation of replicative fitness by using less frequently used synonymous codons
|
|
US7951384B2
(en)
|
2005-08-05 |
2011-05-31 |
University Of Massachusetts |
Virus-like particles as vaccines for paramyxovirus
|
|
WO2008133663A2
(en)
|
2006-11-30 |
2008-11-06 |
Government Of The United States Of America, As Represented By The Secretary, |
Codon modified immunogenic compositions and methods of use
|
|
EP3431099B1
(en)
|
2007-03-30 |
2024-01-03 |
The Research Foundation for The State University of New York |
Attenuated viruses useful for vaccines
|
|
WO2010039224A2
(en)
|
2008-09-30 |
2010-04-08 |
University Of Massachusetts Medical School |
Respiratory syncytial virus (rsv) sequences for protein expression and vaccines
|
|
RU2011122615A
(ru)
|
2008-11-05 |
2012-12-20 |
Мерк Шарп Энд Домэ Корп. |
Живой аттенуированный респираторно-синцитиальный вирус
|
|
PL3067064T3
(pl)
|
2008-12-09 |
2020-11-02 |
Novavax, Inc. |
Zmodyfikowane białka f rsv i sposoby ich wykorzystania
|
|
SI3178490T1
(sl)
|
2009-07-15 |
2022-08-31 |
Glaxosmithkline Biologicals S.A. |
Sestavki proteina F RSV-ja in postopki za pripravo le-teh
|
|
US20110097358A1
(en)
|
2009-10-12 |
2011-04-28 |
Techno Vax, Inc. |
RESPIRATORY SYNCYTIAL VIRUS (RSV) VIRUS-LIKE PARTICLES (VLPs)
|
|
US10227569B2
(en)
|
2011-04-12 |
2019-03-12 |
Emory University |
Respiratory syncytial virus expression vectors
|
|
SI3275892T1
(sl)
*
|
2011-05-13 |
2020-06-30 |
Glaxosmithkline Biologicals S.A. |
Prefuzijski RSV F antigeni
|
|
JP2014520805A
(ja)
|
2011-07-06 |
2014-08-25 |
ナノバイオ コーポレーション |
ヒト呼吸器合胞体ウイルスワクチン
|
|
US8816081B2
(en)
|
2012-08-06 |
2014-08-26 |
Basf Se |
Boron containing perylene monoimides, a process for their production, their use as building blocks for the production of perylene monoimide derivatives, monoimide derivatives and their use in dye-sensitized solar cells
|
|
US9957486B2
(en)
|
2013-02-08 |
2018-05-01 |
The United States Of America, As Represented By The Secretary, Dept. Of Health And Human Services |
Attenuation of human respiratory syncytial virus by genome scale codon-pair deoptimization
|
|
SMT202400297T1
(it)
|
2013-03-13 |
2024-09-16 |
The United States Of America As Represented By The Secretary Department Of Health And Human Services |
Proteine f del rsv pre-fusione e loro uso
|
|
US9738689B2
(en)
*
|
2013-03-13 |
2017-08-22 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Prefusion RSV F proteins and their use
|
|
US9060975B2
(en)
*
|
2013-03-14 |
2015-06-23 |
Mucosis Bv |
Heat-stable respiratory syncytial virus F protein oligomers and their use in immunological compositions
|
|
AU2014239583B2
(en)
|
2013-03-14 |
2020-07-02 |
Children's Healthcare Of Atlanta, Inc. |
Recombinant RSV with silent mutations, vaccines, and methods related thereto
|